Role of Neutrophil Extracellular Traps in AAA Pathogenesis

中性粒细胞胞外陷阱在 AAA 发病机制中的作用

基本信息

  • 批准号:
    9111039
  • 负责人:
  • 金额:
    $ 39.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2018-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Neutrophils are the early responders to acute inflammation during vessel wall injury or insult. Apart from phagocytosis and degranulation, NETosis (formation of Neutrophil Extracellular Trap or NET) is another aspect of neutrophil-mediated defense mechanism. Multiple proteins/enzymes such as histones, neutrophil elastase and myeloperoxidase are released along with NETs. Therefore, induction of NETosis in sterile inflammation is deleterious for many chronic diseases such as atherosclerosis. Abdominal aortic aneurysms (AAAs) remain a life-threatening disease in US adults with no available nonsurgical therapies highlighting a great need to develop a treatment strategy. During AAA formation, aortic wall undergoes major pathological changes with degradation of extracellular matrix and marked infiltration of inflammatory cells, such as neutrophils and lymphocytes. In murine experimental models, neutrophils have been detected in early stages of AAA growth. Recently, we have shown that genetic (IL-1ß and IL-1R1 deficiency in mice) and pharmacological (anakinra treatment) inhibition of IL-1ß signaling protect mice from AAA formation with significant reduction in aortic infiltration of inflammatory cells including neutrophils. Our preliminary result and published literatures suggest that IL-1ß induces NETosis in neutrophils. Therefore, we hypothesize that aortic IL-1ß induces NETosis and exacerbates inflammation in AAA. To test this hypothesis, we are proposing three specific aims. First we will test if genetic and pharmacological inhibition of IL-1ß signaling suppress NETosis and the AAA growth in mice. For these aims, we will use C57BL/6 (wild-type, WT), IL-1ß knockout (KO) and IL-1R1 KO mice, mouse AAA models such as elastase perfusion and angiotensin II infusion, knockdown IL-1ß or IL-1R1 using AMAXA Nucleofector, adoptive transfer of IL-1R1 KO neutrophils to neutrophil depleted WT mice. To examine and quantify NETosis, we will use the state-of-the-arts immunohistochemistry, confocal and intravital microscopy, and imaging flow cytometry. We will show that NET formation promotes inflammation and AAA growths, and, pharmacological inhibition of NETosis by (i) impairing IL-1ß signaling (using anakinra) and (ii) degrading NETs (using DNase), suppresses AAA growth in mice. We will further test the hypothesis that human neutrophils exhibit IL-1ß-dependent NETosis and induce inflammation in human aortic wall ex vivo. We will use proteomics approaches to identify proinflammatory proteins in human NETs, use human aortic explants to examine inflammatory response of IL-1b-induced NETs and parallel flow chambers to examine IL-1ß-induced NET-mediated immune cell recruitment from blood. Altogether, this proposal includes innovative concept that IL-1ß synthesized in aortic wall induces NETosis leading to increased tissue inflammation and AAA growth, and innovative methods to reduce NETosis and suppress AAA growth. These aims when achieved will provide the foundation for developing novel therapies for AAAs in human.
描述(由申请方提供):中性粒细胞是血管壁损伤或损伤期间急性炎症的早期反应者。除了吞噬作用和脱粒作用之外,NETosis(形成神经细胞外陷阱或NET)是嗜中性粒细胞介导的防御机制的另一个方面。多种蛋白质/酶如组蛋白、嗜中性粒细胞弹性蛋白酶和髓过氧化物酶与NET一起沿着释放。因此,在无菌性炎症中诱导NETosis对许多慢性疾病如动脉粥样硬化是有害的。腹主动脉瘤(AAA)在美国成人中仍然是一种危及生命的疾病,没有可用的非手术治疗方法,这突出了制定治疗策略的迫切需要。在AAA形成过程中,主动脉壁经历了主要的病理变化,细胞外基质降解和显著的炎性细胞(如中性粒细胞和淋巴细胞)浸润。在鼠实验模型中,在AAA生长的早期阶段检测到中性粒细胞。最近,我们已经表明,遗传(小鼠中的IL-1 β和IL-1 R1缺乏)和药理学(阿那白滞素治疗)抑制IL-1 β信号传导可保护小鼠免于AAA形成,并显著减少炎性细胞(包括中性粒细胞)的主动脉浸润。我们的初步结果和已发表的文献表明,IL-1 β诱导中性粒细胞NETosis。因此,我们假设主动脉IL-1 β诱导NETosis并加重AAA中的炎症。为了验证这一假设,我们提出了三个具体目标。首先,我们将测试是否遗传和药理学抑制IL-1 β信号转导抑制NETosis和AAA生长的小鼠。为了这些目的,我们将使用C57 BL/6(野生型,WT)、IL-1 R1敲除(KO)和IL-1 R1 KO小鼠、小鼠AAA模型(如弹性蛋白酶灌注和血管紧张素II输注)、使用AMAXA Nucleofector敲低IL-1 R1或IL-1 R1、将IL-1 R1 KO中性粒细胞过继转移至中性粒细胞耗尽的WT小鼠。为了检查和量化NETosis,我们将使用最先进的免疫组织化学,共聚焦和活体显微镜,以及成像流式细胞术。我们将证明NET形成促进炎症和AAA生长,并且通过(i)损害IL-1 β信号传导(使用阿那白滞素)和(ii)降解NET(使用DNA酶)药理学抑制NETosis,抑制小鼠AAA生长。我们将进一步检验人中性粒细胞表现出IL-1 β依赖性NETosis并诱导离体人主动脉壁炎症的假设。我们将使用蛋白质组学的方法来确定促炎蛋白在人类NET,使用人主动脉外植体检查IL-1b诱导的NET和平行流动室的炎症反应,检查IL-1b诱导的NET介导的免疫细胞从血液中招募。总而言之,该提案包括主动脉壁中合成的IL-1 β诱导NETosis导致组织炎症增加和AAA生长的创新概念,以及减少NETosis和抑制AAA生长的创新方法。这些目标一旦实现,将为开发治疗人类AAAs的新疗法提供基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gilbert Rivers Upchurch其他文献

Aromatase Deletion Accelerates Female Experimental Abdominal Aortic Aneurysm Formation
  • DOI:
    10.1016/j.jvs.2013.07.042
  • 发表时间:
    2013-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    William Forrest Johnston;Gang Su;Morgan Salmon;Guanyi Lu;Emilie F. Rissman;Gorav Ailawadi;Gilbert Rivers Upchurch
  • 通讯作者:
    Gilbert Rivers Upchurch
Artificial Intelligence for Predicting Complication with Live-Streaming Data: Prospective MySurgeryRisk Validation
  • DOI:
    10.1016/j.jamcollsurg.2020.07.256
  • 发表时间:
    2020-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Tyler John Loftus;Chris Giordano;Gilbert Rivers Upchurch;Azra Bihorac
  • 通讯作者:
    Azra Bihorac

Gilbert Rivers Upchurch的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gilbert Rivers Upchurch', 18)}}的其他基金

Role of Neutrophil Extracellular Traps in AAA Pathogenesis
中性粒细胞胞外陷阱在 AAA 发病机制中的作用
  • 批准号:
    9700321
  • 财政年份:
    2014
  • 资助金额:
    $ 39.5万
  • 项目类别:
Role of Neutrophil Extracellular Traps in AAA Pathogenesis
中性粒细胞胞外陷阱在 AAA 发病机制中的作用
  • 批准号:
    9321216
  • 财政年份:
    2014
  • 资助金额:
    $ 39.5万
  • 项目类别:
Role of Neutrophil Extracellular Traps in AAA Pathogenesis
中性粒细胞胞外陷阱在 AAA 发病机制中的作用
  • 批准号:
    8765843
  • 财政年份:
    2014
  • 资助金额:
    $ 39.5万
  • 项目类别:
Gender Differences in Experimental Aortic Aneurysms
实验性主动脉瘤的性别差异
  • 批准号:
    7842122
  • 财政年份:
    2009
  • 资助金额:
    $ 39.5万
  • 项目类别:
Gender Differences in Experimental Aortic Aneurysms
实验性主动脉瘤的性别差异
  • 批准号:
    8179083
  • 财政年份:
    2007
  • 资助金额:
    $ 39.5万
  • 项目类别:
Gender Differences in Experimental Aortic Aneurysms
实验性主动脉瘤的性别差异
  • 批准号:
    7842508
  • 财政年份:
    2007
  • 资助金额:
    $ 39.5万
  • 项目类别:
Gender Differences in Experimental Aortic Aneurysms
实验性主动脉瘤的性别差异
  • 批准号:
    7477775
  • 财政年份:
    2007
  • 资助金额:
    $ 39.5万
  • 项目类别:
Gender Differences in Experimental Aortic Aneurysms
实验性主动脉瘤的性别差异
  • 批准号:
    7632241
  • 财政年份:
    2007
  • 资助金额:
    $ 39.5万
  • 项目类别:
Gender Differences in Experimental Aortic Aneurysms
实验性主动脉瘤的性别差异
  • 批准号:
    8167383
  • 财政年份:
    2007
  • 资助金额:
    $ 39.5万
  • 项目类别:
Gender Differences in Experimental Aortic Aneurysms
实验性主动脉瘤的性别差异
  • 批准号:
    8918723
  • 财政年份:
    2007
  • 资助金额:
    $ 39.5万
  • 项目类别:

相似海外基金

Establishment of human abdominal aortic aneurysm wall strength prediction model using Ex Vivo Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging
利用Ex Vivo超顺磁性氧化铁建立人体腹主动脉瘤壁强度预测模型
  • 批准号:
    23K08226
  • 财政年份:
    2023
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
血管平滑肌细胞铁死亡与腹主动脉瘤
  • 批准号:
    10733477
  • 财政年份:
    2023
  • 资助金额:
    $ 39.5万
  • 项目类别:
Extracellular Vesicle Delivery System for Treatment of Abdominal Aortic Aneurysm
细胞外囊泡递送系统治疗腹主动脉瘤
  • 批准号:
    10751123
  • 财政年份:
    2023
  • 资助金额:
    $ 39.5万
  • 项目类别:
I-Corps: A Clinical Decision Support Tool to Manage Abdominal Aortic Aneurysm Patients
I-Corps:管理腹主动脉瘤患者的临床决策支持工具
  • 批准号:
    2318665
  • 财政年份:
    2023
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Standard Grant
Atherosclerosis drives arterial damage and abdominal aortic aneurysm formation and rupture
动脉粥样硬化导致动脉损伤和腹主动脉瘤形成和破裂
  • 批准号:
    483212
  • 财政年份:
    2023
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Operating Grants
Development of phospholipid-based nanotherapeutics for treating abdominal aortic aneurysm
开发基于磷脂的纳米疗法治疗腹主动脉瘤
  • 批准号:
    10749980
  • 财政年份:
    2023
  • 资助金额:
    $ 39.5万
  • 项目类别:
Impact of PCSK9 inhibition on abdominal aortic aneurysm pathobiology and growth
PCSK9 抑制对腹主动脉瘤病理学和生长的影响
  • 批准号:
    10566800
  • 财政年份:
    2023
  • 资助金额:
    $ 39.5万
  • 项目类别:
The Role of Amino Acid Starvation Response Kinase GCN2 in Abdominal Aortic Aneurysm
氨基酸饥饿反应激酶 GCN2 在腹主动脉瘤中的作用
  • 批准号:
    10584543
  • 财政年份:
    2022
  • 资助金额:
    $ 39.5万
  • 项目类别:
Atherosclerotic process drives arterial damage, abdominal aortic aneurysm formation, and rupture
动脉粥样硬化过程导致动脉损伤、腹主动脉瘤形成和破裂
  • 批准号:
    477264
  • 财政年份:
    2022
  • 资助金额:
    $ 39.5万
  • 项目类别:
    Operating Grants
Endovascular Orifice Detection (EOrD) Device for in situ Fenestration of Abdominal Aortic Aneurysm
用于腹主动脉瘤原位开窗的血管内孔口检测 (EOrD) 装置
  • 批准号:
    10453104
  • 财政年份:
    2022
  • 资助金额:
    $ 39.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了